MedPath

Pectoralis Minor Release Versus Non-release in RSA

Not Applicable
Not yet recruiting
Conditions
Reverse Total Shoulder Arthroplasty
Advanced Glenohumeral Osteoarthritis
Rotator Cuff Tear Arthropathy
Interventions
Procedure: Pectoralis Minor Release
Procedure: RSA
Registration Number
NCT06292169
Lead Sponsor
Emory University
Brief Summary

The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are:

* whether releasing the pectoralis minor prophylactically could have better pain relief

* whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes

* whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.

Detailed Description

Shoulder arthroplasty has been increasing at exponential rates, particularly due to the rise of reverse shoulder arthroplasty (RSA). Postoperative complications after RSA include infection, instability, hardware component loosening, acromial and scapular spine fractures, neurologic injury, and scapular notching which can all cause pain. However, despite excluding these causes, some patients can have persistent anterior shoulder pain with poor motion.

RSA prostheses work by translating the center of rotation (COR) inferiorly and medially, which increases tension on the deltoid, which is thought to increase the deltoid's mechanical moment arm and thus its ability to abduct and flex the humerus. However, excessive lengthening may be a cause of acromial and scapular spine fractures or neurologic injury. In addition, other structures are tensioned, including the conjoint tendon (short head of the biceps brachii and coracobrachialis) and pec minor (PM). It is unclear if lengthening these muscle-tendon units has functional consequences or whether it can create an intrinsic pathology. It is therefore feasible that muscle lengthening could create tendinitis, which could lead to persistent anterior shoulder pain after RSA. In addition, excessive tension or over-activity in the PM is also known to be a cause of altered scapula biomechanics.

Good scapula biomechanics after RSA are critical to preserving an impingement-free range of motion, which is important in maximizing postoperative outcomes, implant longevity, and preventing component loosening and instability. However, it is known from the non-arthroplasty population that during repetitive movements with scapular protraction, a hyperactive or spasming PM shortens and develops contracture, leading to protracted resting scapular position and altered scapular contribution to shoulder range of motion.1 This causes altered scapular kinematics, or dyskinesia, and alters scapular accommodation to shoulder motion, a well-known feature in various shoulder pathologies. This can be a major problem after RSA when scapula accommodation is critical to ROM and function.

Due to the expendability of the pectoralis minor, its release would cause minimal functional detriment in non-pathological cases, but in cases of overactivity, release could markedly improve scapula biomechanics. This can be performed open or arthroscopically, but the concomitant open release would be straight-forward at the time of the index surgery through the same incision

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • All patients undergoing surgery for reverse total shoulder arthroplasty
  • Patients willing and able to provide informed consent
Exclusion Criteria
  • Revision arthroplasty
  • Reverse shoulder arthroplasty for proximal humerus fractures
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RSA with pectoralis minor releaseRSA-
RSA with pectoralis minor releasePectoralis Minor Release-
RSA without pectoralis minor releaseRSA-
Primary Outcome Measures
NameTimeMethod
Visual analog Scale (VAS) pain scoresBaseline, 6 months

The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Study participants will be asked to rate their current level of pain by placing a mark on the line

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Emory Clinic

🇺🇸

Atlanta, Georgia, United States

Emory Healthcare Orthopaedics and Spine Center

🇺🇸

Atlanta, Georgia, United States

Emory Clinic
🇺🇸Atlanta, Georgia, United States
Eric Wagner, MD
Contact
404-778-7249
eric.r.wagner@emory.edu
Musab Gulzar
Contact
201-344-0298
mgulzar@emory.edu
Michael Gottschalk, MD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath